The Arthritis, Rheumatism and Aging Medical Information System (ARAMIS): Still young at 30 years

Division of Immunology & Rheumatology, School of Medicine, Stanford University, 1000 Welch Rd., Suite 203, Palo Alto, California 94304, USA.
Clinical and experimental rheumatology (Impact Factor: 2.97). 01/2005; 23(5 Suppl 39):S163-7.
Source: PubMed

ABSTRACT Chronic diseases such as atherosclerosis, arthritis, diabetes, and cancer are among major public health concerns. To understand their cumulative risk factors and antecedents, a chronic disease databank consisting of time-oriented, multidisciplinary longitudinal data, prospectively collected on consecutive patients and describing their clinical courses, provides a systematic anthology of patient reported outcome (PRO) data. ARAMIS, which began in the mid-1970s, was the first large-scale chronic disease data bank system. Outcomes data are collected using the Health Assessment Questionnaire (HAQ), a well established PRO instrument that collects patient-centered data in the areas of disability, pain and other symptoms, adverse effects of treatment, economic impact, and mortality. More than 900 peer-reviewed studies have emanated from ARAMIS since its inception. In the earlier days, and even today, ARAMIS had to invent its own tools for the study of these new sciences. ARAMIS has made dominant contributions to the understanding of PROs and to helping improve treatment and health outcomes in rheumatoid arthritis (RA), osteoarthritis (OA), scleroderma, lupus, aging, and drug side effects. It continues to traverse terrain with participation in the NIH "Roadmap" project, the Patient Reported Outcome Measurement Information System (PROMIS). PROMIS is designed to provide improved assessment of health status across all chronic illnesses as part of an improved infrastructure for clinical research. As initiator of the rich history of chronic disease data banks with "rolling" consecutive open patient cohorts, ARAMIS has enabled the study of real-world PROs in rheumatology, with a wealth of resultant improved approaches to treatment, outcome, cost effectiveness, and quality of life.

Download full-text


Available from: James F Fries, May 28, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this chapter is to dig deeper into the nature of computer-based clinical decision support, in terms of the ways in which it is or potentially could be used, its design, and its interaction with host environments. I believe that understanding these aspects of CDS is important as a foundation for serious efforts to increase its dissemination and adoption. As pointed out in previous chapters, and as will be explored in more detail in Section II, much of the success with CDS has been with on-off implementations that have been difficult to maintain over time even within their own institutions, more problematic when extended for use throughout a health care enterprise, and only rarely replicated elsewhere despite demonstrated effectiveness. If we are to tackle this issue and break down barriers to dissemination and adoption, we need to know what we are working with, which aspects are most troublesome and how they can be improved, and which components or interfaces can be standardized or made easier to deploy. We also need to understand the human factors and process and workflow implications of CDS use, so that we can determine optimal approaches to invocation and user interface design. An underlying thesis is that CDS has a conceptual architecture comprised of a number of design elements or components. Many kinds of CDS are designed without the architecture being explicit, but I will try to demonstrate that all the design elements nonetheless are present, even if implicit. A second thesis is that CDS does not function in isolation, but rather that it operates in the context of some sort of application environment. However, in the discus-sion to follow, I will consider the chunk of software that provides CDS as a ''module'' of software that interacts with the application environment, recog-nizing full well that often CDS implementations are not modular at all, and that the dividing line between what constitutes CDS and what constitutes the application that invokes it is not clearly defined, so that the two cannot be cleanly separated. Even so, we can think of the functions that are performed as being done by either the application environment or by the CDS software, so that responsibilities for these functions can be assigned to one or the other. These two conceptual idealizations—1) an underlying component archi-tecture for CDS, and 2) modularity of CDS in that its tasks and responsibilities can be separated from those of the application environment with which it interacts—are helpful to better understand how to design CDS in a portable, reusable, maintainable fashion. I believe that, in adopting this approach, it will also be possible to design more robust versions of existing CDS that have the ability to interoperate in other platforms, be adapted to differing applica-tion settings, be maintained and updated more readily, and thus be more widely disseminated and used. So this chapter is about design principles. But as you will quickly con-clude, this topic is a work in progress. There are many complexities, nuances, and unresolved questions yet to be answered by researchers and developers in this field. My goal is to call attention to these design principles and challenges as a framework for further work, in the belief that this will help to accelerate our progress in dissemination and adoption.
  • Nature Clinical Practice Rheumatology 04/2006; 2(3):114-5. DOI:10.1038/ncprheum0131 · 5.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The National Database of the German Collaborative Arthritis Centres is the most important source for the evaluation of current health care for German rheumatology patients. Since 1993, all outpatients with inflammatory rheumatic diseases treated in one of 24 arthritis centres have been recorded once a year using a clinical record form and a patient questionnaire. The aim is to gain knowledge on the outcomes and the medical, social and economic consequences of inflammatory rheumatic diseases in the real world, and to monitor continuously the current state and trends in health care. Data from more than 200,000 patients with inflammatory rheumatic diseases from 11 years (1993-2003) are available, making it possible to analyse even very rare diseases with a sufficient numbers of cases. Selected results on the health care situation, practice variation in rheumatology and the burden of illness in various diseases are reported.
    Zeitschrift für Rheumatologie 04/2006; 65(2):144, 146-51. DOI:10.1007/s00393-006-0042-7 · 0.46 Impact Factor
Show more